Quarterly report pursuant to Section 13 or 15(d)

Accrued Expenses and Other Current Liabilities - Schedule of Accrued Expenses and Other Current Liabilities (Details)

v3.24.3
Accrued Expenses and Other Current Liabilities - Schedule of Accrued Expenses and Other Current Liabilities (Details) - USD ($)
$ in Thousands
Sep. 30, 2024
Dec. 31, 2023
Accrued Liabilities, Current [Abstract]    
External research and preclinical development $ 9,984 $ 8,001
Employee compensation and benefits 4,788 6,993
Professional fees 707 1,015
Facilities and other 683 137
Accrued expenses and other current liabilities $ 16,162 $ 16,146